Otolaryngology head and neck surgery

[1] Califano J, 1996, CANCER RES, V56, P2488

[2] CLARY R, 1996, HEAD NECK SURG, V122, P1189

[3] COHEN H, 1995, ARCH OTOLARYNGOL, V121, P29

[4] Gates GA, 1996, ARCH OTOLARYNGOL, V122, P161

[5] The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer [J]. LARYNGOSCOPE, 1996, 106 (11) : 1378 - 1381

[6] HARALDSSON PO, 1995, ARCH OTOLARYNGOL, V121, P90

[7] Johns ME, 1996, ARCH OTOLARYNGOL, V122, P1039

[8] Johns MM, 1996, CANCER RES, V56, P1151

[9] p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21): : 1580 - 1586

[10] Quantitative criteria for predicting thyroplasty type I outcome [J]. LARYNGOSCOPE, 1996, 106 (06) : 689 - 693

[1] Califano J, 1996, CANCER RES, V56, P2488

[2] CLARY R, 1996, HEAD NECK SURG, V122, P1189

[3] COHEN H, 1995, ARCH OTOLARYNGOL, V121, P29

[4] Gates GA, 1996, ARCH OTOLARYNGOL, V122, P161

[5] The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer [J]. LARYNGOSCOPE, 1996, 106 (11) : 1378 - 1381

[6] HARALDSSON PO, 1995, ARCH OTOLARYNGOL, V121, P90

[7] Johns ME, 1996, ARCH OTOLARYNGOL, V122, P1039

[8] Johns MM, 1996, CANCER RES, V56, P1151

[9] p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21): : 1580 - 1586

[10] Quantitative criteria for predicting thyroplasty type I outcome [J]. LARYNGOSCOPE, 1996, 106 (06) : 689 - 693